Canopy Growth CORP

Canopy Growth Corporation announced its fiscal fourth quarter and full-year 2026 financial results, highlighting a 6% increase in consolidated net revenue for the full year to $284.6 million, driven by strong performance in its Canadian medical and adult-use cannabis segments.

Canopy Growth Corporation has adopted an Advance Notice By-Law to formalize director nominations, requiring specific disclosures and deadlines for shareholder nominations.

Canopy Growth Corporation announced it will restate previously issued financial statements for fiscal years 2024 and 2025 due to a non-cash technical accounting error related to share-settled warrants.

Canopy Growth Corporation has completed its acquisition of MTL Cannabis Corp., creating Canada's leading medical cannabis platform and strengthening its adult-use business.

Canopy Growth Corporation reported a 49% year-over-year reduction in net loss for Q3 FY2026, driven by strong Canadian cannabis sales and cost savings.

Canopy Growth Corporation announced strategic recapitalization transactions, including a new US$150 million senior secured loan and an exchange of C$96.4 million in convertible debentures, extending debt maturities to 2031 and enhancing liquidity.

Canopy Growth reported significantly reduced net losses and improved cash flow, driven by debt restructuring and new financing, despite ongoing gross margin pressures and a key U.S. investment default.

Canopy Growth reported significantly reduced net losses and improved cash flow, resolving prior going concern doubts, driven by strategic debt reduction and strong Canadian cannabis sales.

Canopy Growth Corporation reported a significantly reduced net loss and improved cash flow from operations in Q1 2026, driven by strategic cost reductions and increased cannabis sales, despite declining gross margins and ongoing legal challenges.

Canopy Growth's Q3 2025 results show a net revenue decrease but improved gross margin and reduced operating expenses, alongside strategic moves in the U.S. market and debt management.

Canopy Growth's second quarter fiscal 2025 results show a decrease in revenue but an improvement in gross margin percentage compared to the same period last year.

Canopy Growth's first quarter of fiscal year 2025 saw a decrease in revenue but a significant improvement in gross margin compared to the same period last year.

Canopy Growth Corporation has filed its Form 10-K for the fiscal year ended March 31, 2026, detailing financial restatements due to accounting errors related to share-settled warrants and reporting a reduced net loss compared to the prior year.

Canopy Growth Corporation reported a significant increase in net loss for fiscal year 2025, reaching C$604.1 million, despite improvements in gross margin and a reduction in Adjusted EBITDA loss, as the company continues its strategic shift towards an asset-right model and U.S. market entry.

Canopy Growth Corporation's annual 10-K filing outlines a strategic shift towards an asset-light model, focusing on brand building and U.S. market entry through Canopy USA.

Canopy Growth Corp. Director Joseph Bayern disposed of 3,197 common shares due to tax obligations related to vested restricted stock units.

Canopy Growth Corp. Director Theresa Yanofsky reported a disposition of 15,054 common shares due to tax obligations related to the vesting of restricted stock units.

Canopy Growth Corp. Director M. Shan Atkins disposed of 3,197 common shares due to tax obligations related to vested restricted stock units.

Canopy Growth Corp. director David Angelo Lazzarato disposed of 22,674 common shares due to tax obligations related to the vesting of restricted stock units.

Director Theresa Yanofsky sold 10,373 common shares of Canopy Growth Corporation to satisfy tax obligations related to RSU vesting.

Canopy Growth Corp's CEO, Luc Mongeau, disposed of 9,376 common shares to cover tax obligations related to RSU vesting.

Canopy Growth Corporation adjourned its annual general and special meeting of shareholders to October 10, 2025, after failing to achieve the necessary quorum.

Canopy Growth Corporation has extended its proxy voting deadline to September 26, 2025, at 9:00 AM ET to ensure a quorum for its upcoming annual general and special meeting.

Canopy Growth Corporation is urging shareholders to vote ahead of its Annual General and Special Meeting to ensure quorum and avoid potential delays and additional costs.

Leading independent proxy advisory firm Institutional Shareholder Services Inc. (ISS) has recommended Canopy Growth shareholders vote FOR all resolutions at the upcoming Annual General and Special Meeting.

Canopy Growth Corporation is soliciting shareholder votes for its 2025 Annual and Special Meeting to ensure quorum and transact business.

Canopy Growth Corporation initiated a proxy solicitation program on August 19, 2025, targeting shareholders with Robinhood accounts to facilitate electronic voting.

Canopy Growth Corporation has filed an S-1 registration statement for the resale of up to 1,086,279 common shares by selling securityholders.

Canopy Growth Corporation has filed a registration statement for the resale of up to 16,317,020 common shares by selling securityholders following a private placement.